Bold Therapeutics at BIO-Europe 2026

Nov 9–11, 2026 Cologne, Germany ~5.8k attendees Website

Bold Therapeutics at BIO-Europe 2026 in Cologne: 1 session (1 talk).

OrganizationBIO-Europe 2026 Attendance
Bold Therapeutics
Vancouver, Canada
bold-therapeutics.com
Biotech
Clinical-stage company developing metal-based cancer drugs, led by BOLD-100.
Talk
Mon Nov 9
13:15–13:30
Oncology: Bold Therapeutics Inc.
A ruthenium-based cancer drug in mid-stage trials for advanced digestive tract cancers that also seems to protect nerves from chemotherapy damage.

Explore the full BIO-Europe 2026 dataset

Get in-depth attendee and institution profiles and research, to plan your meetings in Cologne. Leave your work email and we’ll be in touch.

Privacy

Download the full BIO-Europe 2026 CSV

Leave your work email and we’ll be in touch. The CSV adds attendee names, roles and contact details to the company and session data shown here.

Privacy

Instantly find 20 buyers from Bold Therapeutics

Get a list of who you should contact, their contact info, and what to say.

Totally free and instant, no sign up necessary!

Not affiliated with or endorsed by BIO-Europe or its organizers. Submit a correction